| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/11/2002 | CA2433174A1 Cholesterol biosynthesis inhibitor containing tricyclic compound having spiro union as effective component |
| 07/11/2002 | CA2432853A1 Protection, restoration, and enhancement of erythropoietin-responsive cells, tissues and organs |
| 07/11/2002 | CA2432409A1 Tropolone derivative |
| 07/11/2002 | CA2432339A1 Identification of the genetic determinants of the polymorphic cyp3a5 expression |
| 07/11/2002 | CA2431041A1 New drug combinations of norepinehrine reuptake inhibitors and neuroleptic agents |
| 07/11/2002 | CA2428351A1 Method for detoxifying a carbohydrate containing solution |
| 07/10/2002 | EP1221615A2 S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy |
| 07/10/2002 | EP1221477A2 Transfection of vertebrate cells e.g. by homologous recombination |
| 07/10/2002 | EP1221444A1 Fused imidazole compounds and remedies for diabetes mellitus |
| 07/10/2002 | EP1221440A1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators |
| 07/10/2002 | EP1220947A2 50 human secreted proteins |
| 07/10/2002 | EP1220932A1 Human carboxypeptidases and polynucleotides encoding the same |
| 07/10/2002 | EP1220929A1 Human ubiquitin protease |
| 07/10/2002 | EP1220918A2 Hepatoma-derived growth factor-like proteins, polynucleotides encoding them and methods of use |
| 07/10/2002 | EP1220906A1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby |
| 07/10/2002 | EP1220900A2 Gene transfer vectors for treating autoimmune diseases and diseases with immunopathogenesis by therapy |
| 07/10/2002 | EP1220865A1 43 human secreted proteins |
| 07/10/2002 | EP1220863A1 Purine derivatives |
| 07/10/2002 | EP1220862A1 Purine derivatives |
| 07/10/2002 | EP1220856A2 Pyrazolo[4,3-d]pyrimidine derivatives |
| 07/10/2002 | EP1220852A1 Substituted diazepans |
| 07/10/2002 | EP1220843A1 Pyridinium derivatives for the treatment of diabetic and aging-related vascular complications |
| 07/10/2002 | EP1220839A2 Hydroxyfunctional amide 1h-indole derivatives active as spla2 inhibitors |
| 07/10/2002 | EP1220832A1 Novel aromatic compounds |
| 07/10/2002 | EP1220831A1 Biaryl ether derivatives useful as monoamine reuptake inhibitors |
| 07/10/2002 | EP1220673A2 Morpholinol derivatives for the treatment of obesity |
| 07/10/2002 | EP1220669A1 Therapeutic intervention to mimic the effect of caloric restriction |
| 07/10/2002 | EP1220620A1 Composition comprising casein protein and whey protein |
| 07/10/2002 | EP1098657B1 Green tea extracts containing catechols and caffeine |
| 07/10/2002 | EP0998296B1 Pharmaceutical uses of cypress |
| 07/10/2002 | EP0914158B1 Pharmaceutical combination containing a compound having angiotensin ii antagonistic activity and a compound which increases the insulin-sensitivity |
| 07/10/2002 | EP0679088B1 Pulmonary delivery of active fragments of parathyroid hormone |
| 07/10/2002 | CN1358193A Steroid compounds with C17-alkyl side chain and aromatic A-ring for use in therapy |
| 07/10/2002 | CN1358192A 嘌呤衍生物 Purine derivatives |
| 07/10/2002 | CN1358184A 新药物 New Drug |
| 07/10/2002 | CN1358179A Thiazole and oxazole derivatives and their pharmaceutical use |
| 07/10/2002 | CN1358175A Pyrimidinone compounds |
| 07/10/2002 | CN1358096A Remedies for diabetes |
| 07/10/2002 | CN1358094A Method for treating chronic pain using MEK inhibitors |
| 07/10/2002 | CN1358092A Pharmaceutical composition containing sibutramine and orlistat |
| 07/10/2002 | CN1358062A 巨噬细胞清除剂受体拮抗剂 Macrophage scavenger receptor antagonists |
| 07/10/2002 | CN1357360A Hypoglycemic biopreparation |
| 07/10/2002 | CN1357326A Composition containing calcium ascorbate and calcium L-threonate |
| 07/10/2002 | CN1087289C Novel process for the production of amorphous [R-(R,R.)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt |
| 07/10/2002 | CN1087288C Crystalline [R-(R+,R+)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(5-methylethyl)-3-phenyl-4-(phenylamino) carbonyl]-1H-pyrole-1-heptanoic acid hemi-calcium salt (atorvastatin) |
| 07/10/2002 | CN1087285C Basic group substituted benzoyl guaniazine, its preparing process, its use as medicine or diagnostic reagent, and medicine containing the same |
| 07/10/2002 | CN1087174C Health tea for reducing blood sugar, blood fat |
| 07/10/2002 | CN1087171C Compound prepn. contg. multivitamins, minerals and trace elements suitable for chinese people |
| 07/09/2002 | US6417371 Process for preparing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl-acetic acid |
| 07/09/2002 | US6417237 Macromolecular drug complexes and compositions containing the same |
| 07/09/2002 | US6417233 Benzoquinone coenzyme q10 |
| 07/09/2002 | US6417232 Fatty acid analogues for the treatment of primary and secondary restenosis |
| 07/09/2002 | US6417227 Methods of delivery of cetyl myristoleate |
| 07/09/2002 | US6417219 Enzyme inhibitors and osteoarthritis |
| 07/09/2002 | US6417218 Substituted imidazoles, their preparation and use |
| 07/09/2002 | US6417215 Calcilytic compounds |
| 07/09/2002 | US6417212 Modulators of peroxisome proliferator activated receptors |
| 07/09/2002 | US6417192 Pyrimidinone compounds and pharmaceutical compositions containing them |
| 07/09/2002 | US6417188 Arylalkanoylpyridazines |
| 07/09/2002 | US6417185 Heterocyclic enzyme inhibitors |
| 07/09/2002 | US6417176 Arylsulfonanilide phosphates |
| 07/09/2002 | US6417173 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
| 07/09/2002 | US6417164 Treatment of noninsulin diabetes with amylin agonist |
| 07/09/2002 | US6416991 Genetic engineered protein |
| 07/09/2002 | US6416794 Methods and compositions for treating cataracts using substances derived from yeast or saltbush |
| 07/09/2002 | US6416765 Botulinum toxin injected into the pancreas |
| 07/09/2002 | CA2273420C Matrix tablet permitting sustained release of gliclazide after oral administration |
| 07/09/2002 | CA2229624C Method of reducing bodyweight and treating obesity |
| 07/09/2002 | CA2219475C Pharmaceutical composition of fenofibrate presenting a high biodisponibility and its preparation process |
| 07/04/2002 | WO2002052009A1 Human fgf23 protein mutant lowering blood phosphorus level |
| 07/04/2002 | WO2002052001A1 Method of identifying dna encoding physiologically active polypeptide in mammalian body |
| 07/04/2002 | WO2002051983A2 Novel compounds and compositions as cathepsin inhibitors |
| 07/04/2002 | WO2002051844A1 Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands |
| 07/04/2002 | WO2002051839A1 5-'4-'2-(n-methyl-n- (2-pyridyl)amino)ethoxy!benzyl!thiazolidine-2, 4-dione mesylate salt |
| 07/04/2002 | WO2002051838A1 Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists |
| 07/04/2002 | WO2002051836A1 Dipeptidyl peptidase iv inhibitor |
| 07/04/2002 | WO2002051835A1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives |
| 07/04/2002 | WO2002051814A1 Benzoylpyridazines |
| 07/04/2002 | WO2002051809A1 Piperidine mch antagonists and their use in the treatment of obesity |
| 07/04/2002 | WO2002051807A1 Compounds |
| 07/04/2002 | WO2002051806A1 Carbazole derivatives and their use as neuropeptide y5 receptor ligands |
| 07/04/2002 | WO2002051805A1 Indole derivatives as ligands of thyroid receptors |
| 07/04/2002 | WO2002051804A1 Crystalline forms of atorvastatin |
| 07/04/2002 | WO2002051799A1 Biphenyl derivatives |
| 07/04/2002 | WO2002051796A1 Amide derivatives |
| 07/04/2002 | WO2002051442A1 Concomitant drugs |
| 07/04/2002 | WO2002051441A1 Medicinal compositions containing diuretic and insulin resistance-improving agent |
| 07/04/2002 | WO2002051433A2 Use of artemin, a member of the gdnf ligand family for preparing a neuroprotective medicament |
| 07/04/2002 | WO2002051428A1 Sympathetic-activating perfume composition |
| 07/04/2002 | WO2002051417A1 Thermofomable solid pharmaceutical composition for controlled release of trimetazidine |
| 07/04/2002 | WO2002051405A1 New clinical treatment |
| 07/04/2002 | WO2002051398A1 Choline pyruvate, method for the production thereof, formulations containing choline pyruvate and the use thereof |
| 07/04/2002 | WO2002051397A1 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same |
| 07/04/2002 | WO2002051396A1 Pharmaceutical compositions containing cyclobutene derivatives |
| 07/04/2002 | WO2002051389A2 Aerogel powder comprising therapeutic agents |
| 07/04/2002 | WO2002051355A2 Acetyl-coenzyme a carboxylase 2 as a target in fat regulation and insulin action |
| 07/04/2002 | WO2002051264A2 Nutritional composition with health promoting action containing oligo-saccharides |
| 07/04/2002 | WO2002051232A2 Novel benzazepines and related heterocyclic derivatives |
| 07/04/2002 | WO2002038543A3 3-substituted oxindole beta 3 agonists |
| 07/04/2002 | WO2002032373A3 Estrogen receptor modulators |